Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources

ESMO Immuno-Oncology Congress 2023

06 - 08 Dec 2023

Geneva, Switzerland

ESMO-Immuno-Oncology-2023-1000x1000

Abstracts and ePosters: Open Access
Slides and Webcasts: Available to ESMO Members and registered delegates, subject to presenters' consent

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties. ESMO thanks the authors for their generosity.

Meeting programme

From the basics of immunotherapies to the latest research results; from understanding different treatment options to the management of toxicities and interpretation of new data, the ESMO Immuno-Oncology Congress caters to the diverse needs of oncology stakeholders with an interest in this topical field of cancer treatment.

Login to access the resources: Abstracts, slides, webcasts and ePosters.

ESMO Colloquium supported by Novocure: Therapeutic applications and synergies of electric fields in oncology
Watch the session

Hide
Filter by:
Search:
Reset

There are 304 resources available

Welcome and introduction

Presenter: Jennifer Guerriero

Session: Collaborative session ESMO-SITC

Resources:

Webcast

Yes

Presenter: Francois Ghiringhelli

Session: Is TMB a good predictive biomarker for immunotherapy?

Resources:

Slides

Webcast

Invited Discussant 119O

Presenter: Anna Di Giacomo

Session: Proffered Paper session 2

Resources:

Slides

Webcast

No

Presenter: Benoit Rousseau

Session: Is TMB a good predictive biomarker for immunotherapy?

Resources:

Slides

Webcast

Q&A

Presenter: All Speakers

Session: Collaborative session ESMO-SITC

Resources:

Webcast

Q&A

Presenter: All Speakers

Session: Proffered Paper session 2

Resources:

Webcast

Second vote and conclusions

Presenter: Aurelien Marabelle

Session: Is TMB a good predictive biomarker for immunotherapy?

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.